1Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA betacoronavirus responsible for coronavirus disease 2019 (COVID-19), has already caused nearly four million deaths around the world according to the WHO data.
Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, et al. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol. 2021;91:107245. doi: 10.1016/j.intimp.2020.107245. PubMed PMID: 33348292; PubMed Central PMCID: PMCPMC7705326.
Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11-30. doi: 10.1038/s41574-020-00435-4. PubMed PMID: 33188364; PubMed Central PMCID: PMCPMC7664589.
Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol. 2020;88:106924. doi: 10.1016/j.intimp.2020.106924. PubMed PMID: 32877828; PubMed Central PMCID: PMCPMC7441891.
Al-Abdouh A, Bizanti A, Barbarawi M, Jabri A, Kumar A, Fashanu OE, et al. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials. Contemp Clin Trials. 2021;101:106272. doi: 10.1016/j.cct.2021.106272. PubMed PMID: 33422642; PubMed Central PMCID: PMCPMC7789823.
Singh S, Khera D, Chugh A, Khera PS, Chugh VK. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis. BMJ Open. 2021;11:e048416. doi: 10.1136/bmjopen-2020-048416. PubMed PMID: 34168031; PubMed Central PMCID: PMCPMC8228818.
